Vigilare Wealth Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Vigilare Wealth Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,200	Closed	-$387K	–	206
2021 Q3	$387K	Buy	19,200 +11,900	+163%	+$329K	0.24%	116
2021 Q2	$272K	Buy	+7,300	New	+$224K	0.17%	160

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Vigilare Wealth Management's DRNA Position: Q4 2021 in Review

Vigilare Wealth Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 19,200 shares — an estimated $387K sold.

Vigilare Wealth Management first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $387K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Vigilare Wealth Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Vigilare Wealth Management sold 19,200 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $387K.
Vigilare Wealth Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Vigilare Wealth Management's Dicerna Pharmaceuticals, Inc. position peaked at $387K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Vigilare Wealth Management's 13F filing for Q4 2021, filed 7 Jan 2022.